Genomewide Expression Profiling of Cryptolepine-Induced Toxicity in Saccharomyces cerevisiae

ABSTRACT We have used the budding yeast Saccharomyces cerevisiae to identify genes that may confer sensitivity in vivo to the antimalarial and cytotoxic agent cryptolepine. Five S. cerevisiae strains, with different genetic backgrounds in cell permeability and DNA damage repair mechanisms, were exposed to several concentrations of cryptolepine. Cryptolepine showed a relatively mild toxicity for wild-type strains, which was augmented by either increasing cell permeability (Δerg6 or ISE2 strains) or disrupting DNA damage repair (Δrad52 strains). These results are compatible with the ability of cryptolepine to intercalate into DNA and thus promote DNA lesions. The effects of low concentrations of cryptolepine (20% and 40% inhibitory concentrations [IC20 and IC40]) were analyzed by comparing the gene expression profiles of treated and untreated Δerg6 yeast cells. Significant changes in expression levels were observed for 349 genes (117 upregulated and 232 downregulated). General stress-related genes constituted the only recognizable functional cluster whose expression was increased upon cryptolepine treatment, making up about 20% of upregulated genes. In contrast, analysis of the characteristics of downregulated genes revealed a specific effect of cryptolepine on genes related to iron transport or acid phosphatases, as well as a significant proportion of genes related to cell wall components. The effects of cryptolepine on the transcription of iron transport-related genes were consistent with a loss of function of the iron sensor Aft1p, indicating a possible disruption of iron metabolism in S. cerevisiae. Since the interference of cryptolepine with iron metabolism is considered one of its putative antimalarial targets, this finding supports the utility of S. cerevisiae in drug-developing schemes.

[1]  D. Kosman,et al.  The Yeast Copper/Zinc Superoxide Dismutase and the Pentose Phosphate Pathway Play Overlapping Roles in Oxidative Stress Protection* , 1996, The Journal of Biological Chemistry.

[2]  D. Botstein,et al.  A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.

[3]  C. Bailly,et al.  Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis. , 2000, European journal of pharmacology.

[4]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[5]  L. Angenot,et al.  The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells. , 1998, Biochemistry.

[6]  B. Piña,et al.  Daunorubicin-induced variations in gene transcription: commitment to proliferation arrest, senescence and apoptosis. , 2003, The Biochemical journal.

[7]  Kara Dolinski,et al.  Saccharomyces Genome Database (SGD) provides secondary gene annotation using the Gene Ontology (GO) , 2002, Nucleic Acids Res..

[8]  F. Estruch.  Stress-controlled transcription factors, stress-induced genes and stress tolerance in budding yeast. , 2000, FEMS microbiology reviews.

[9]  Juan Aymami,et al.  The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosine-cytosine sites , 2002, Nature Structural Biology.

[10]  B. Piña,et al.  Selective inhibition of yeast regulons by daunorubicin: A transcriptome-wide analysis , 2008, BMC Genomics.

[11]  C. Philpott,et al.  Response to Iron Deprivation in Saccharomyces cerevisiae , 2007, Eukaryotic Cell.

[12]  J. Craig Venter,et al.  Plasmodium, human and Anopheles genomics and malaria , 2002, Nature.

[13]  Ronald W. Davis,et al.  Systematic screen for human disease genes in yeast , 2002, Nature Genetics.

[14]  N. Gooderham,et al.  In vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine. , 2005, Toxicology.

[15]  S. Marin,et al.  Promoter-specific inhibition of transcription by daunorubicin in Saccharomyces cerevisiae. , 2002, The Biochemical journal.

[16]  Sean P. Palecek,et al.  Analyzing the dose-dependence of the Saccharomyces cerevisiae global transcriptional response to methyl methanesulfonate and ionizing radiation , 2006, BMC Genomics.

[17]  I. K. Sawer,et al.  The killing effect of cryptolepine on Staphylococcus aureus , 2005, Letters in applied microbiology.

[18]  L. Angenot,et al.  Antimalarial Activity of Cryptolepine and Some Other Anhydronium Bases , 1996 .

[19]  L. Maes,et al.  In vitro inhibition of beta-haematin formation, DNA interactions, antiplasmodial activity, and cytotoxicity of synthetic neocryptolepine derivatives. , 2004, Experimental parasitology.

[20]  David Botstein,et al.  Transcriptional remodeling in response to iron deprivation in Saccharomyces cerevisiae. , 2003, Molecular biology of the cell.

[21]  G. Jimenez,et al.  Yeast mutants as a model system for identification of determinants of chemosensitivity. , 2000, Pharmacological reviews.

[22]  S. Croft,et al.  Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents. , 2001, Journal of medicinal chemistry.

[23]  D. Botstein,et al.  Genomic expression responses to DNA-damaging agents and the regulatory role of the yeast ATR homolog Mec1p. , 2001, Molecular biology of the cell.

[24]  L. Samson,et al.  Global response of Saccharomyces cerevisiae to an alkylating agent. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Giraldo,et al.  Characterization of the Calcium-mediated Response to Alkaline Stress in Saccharomyces cerevisiae* , 2004, Journal of Biological Chemistry.

[26]  C. Wright.  Recent developments in naturally derived antimalarials: cryptolepine analogues , 2007, The Journal of pharmacy and pharmacology.

[27]  D. Wirth,et al.  Relationship between Chloroquine Toxicity and Iron Acquisition in Saccharomyces cerevisiae , 2002, Antimicrobial Agents and Chemotherapy.

[28]  D. Kosman.  Molecular mechanisms of iron uptake in fungi , 2003, Molecular microbiology.

[29]  J. Wang,et al.  DNA topoisomerase-targeting antitumor drugs can be studied in yeast. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Lazzeroni,et al.  Genome-Wide Identification of Genes Conferring Resistance to the Anticancer Agents Cisplatin, Oxaliplatin, and Mitomycin C , 2004, Cancer Research.